Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes.
Gao J, Zhong W, He J, Li H, Zhang H, Zhou G, Li B, Lu Y, Zou H, Kou G, Zhang D, Wang H, Guo Y, Zhong Y.
Gao J, et al.
Int J Pharm. 2009 Jun 5;374(1-2):145-52. doi: 10.1016/j.ijpharm.2009.03.018. Epub 2009 Mar 24.
Int J Pharm. 2009.
PMID: 19446771